Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor

Experimental and Molecular Medicine

Volumn 41, Issue 3, 2009, Pages 180-188

  Lee, Kyung Hee ^a   Kim, Jae Ryong ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

Hepatocyte growth factor; Metastasis; Mitogen activated protein kinases; Neoplasm metastasis; Reactive oxygen species; Urokinase type plasminogen activator

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DICHLOROFLUORESCEIN; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UROKINASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SYNTHESIS; HEPATOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 65949109906     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.3.021     Document Type: Article

References (37)

1. Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK-MAPKActivity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK1. Cancer Research 2003;63:1684-1695 (Pubitemid 36373662)
2. Andreasen PA, Kjoller L, Christensen L, Nielsen LS, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 1997;72:1-22 (Pubitemid 27314632)
3. Aslan M, Ozben T. Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxidants & Redox Signalling 2003;5:781-788 (Pubitemid 37462061)
4. Berra E, Diaz-Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, et al. Evidence for a role of MEK and MAPK during signal transduction by rotein kinase C zeta. EMBO Journal 1995;14: 6157-6163 (Pubitemid 26007302)
5. Blasi F. The urokinase receptor and cell migration. Semin Thromb Hemost 1996;22:513-516 (Pubitemid 27107335)
6. Bokoch GM, Knaus UG. NADPH oxidases: Not just for leukocytes anymore! Trends in Biochemical Sciences 2005;28:502-508
7. Chiarugi P. PTPs versus PTKs: The redox side of the coin. Free Radical Research 2005;39:353-364
8. Choi MH, Lee IK, Kim GW, Kim BU, Han YH, Yu DY, et al. Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II. Nature 2005;435:347-353
9. Gupta A, Rosenberger SF, Bowden G.T. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progessed mouse keratinocyte cell lines. Carcinogenesis 1999;20:2063-2073 (Pubitemid 29535306)
10. Honore S, Kovacic H, Pichard V, Briand C, Rognoni JB. Alpha2betal-integrin signaling by itself controls GI/S transition in a human adenocarcinoma cell line (Caco-2): Implication of NADPH oxidase-dependent production of ROS. Experimental Cell Research 2003;285:59-71
11. Julio A, Guirre G, Yeriel E, David L, Liliana O. ERK MAPK activity as a determinant of tumor growth and dormancy; regulation by p38SAPk1. Cancer Research 2003;63:1684-1695 (Pubitemid 36373662)
12. Kenmorgant S, Zicha D, Parker PJ. PKC controls HGF-dependent c-Met traffic, signalling and cell migration. EMBO Journal 2004;23:3721-3734 (Pubitemid 39389704)
13. Kozuki Y, Miura Y, Yagasaki K. Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 2000;151:111-115 (Pubitemid 30155592)
14. Kozuki Y, Miura Y, Yagasaki K. Inhibitory effect of curcumin on the invasion of rat ascites hepatoma cells in vitro and ex vivo. Cytotechnology 2001;35:57-63 (Pubitemid 32304977)
15. Kruger JS, Reddy KB. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. Molecular Cancer Research 2003;1:801-809 (Pubitemid 37174451)
16. Kubonishi I, Niiya K, Yamashita M, Yano S, Abe T, Ohtsuki Y, et al. Characterization of a new human lymphoma cell line (RC-K8) with t(11;14) chromosome abnormality. Cancer 1986;58:1453-1460
17. Lee KH, Hyun MS, Kim JR. Invasion-metastasis by hepatocyte growth factor/c-Met signaling concomitant with induction of urokinase plasminogen activator in human pancreatic cancer: Role as therapeutic target. Cancer Research and Treatment 2003;35:207-212
18. Liotta LA, Wewer U, Rao NC, Schiffmann E, Stracke M, Guirguis R, Thorgeirsson U, Muschel RM, Sobel M. Biochemical mechanism of tumor invasion and metastasis. Prog Clin Biol Res 1988;2563-2616
19. Maulik A, Shrikhande T. Kijima PC, Ma PT, Morrison RS. Roleof the hepatocyte growth factor receptor, c-Met. in oncogenesis and potential for therapeutic inhibition. Cytokine Growth Factor Rev 2002;13:41-59 (Pubitemid 34436961)
20. Miura Y, Kozuki Y, Yagasaki K. Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor. Biochem Biophys Res Commun 2003;305:160-165 (Pubitemid 36535422)
21. Miyazono T, Niiya K, Kiguchi T, Sakuragawa N, Harada M, Watanabe A. Oxidative stress induces urokinase-type plasminogen activator in RC-K8 human malignant lymphoma cells and H69 human small cell lung carcinoma cells. Fibrinolysis Proteolysis 2004;14:366-373
22. Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1. Cell Death and Differention 2003;10:508-515 (Pubitemid 36656640)
23. Parr C, Jiang WG. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human canccr cells. Int J Oncol 2001;19:857-863
24. Poli G, Leonarduzzi G, Biasi F, Chiarpotto E. Oxidative stress and cell signalling. Current Medicinal Chemistry 2004;11:1163-1182 (Pubitemid 38585060)
25. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac-lb and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005;436:123-127
26. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9:180-186 (Pubitemid 27135985)
27. Rudolph J. Redox regulation of the Cdc25 phosphatases. Antioxidants and Redox Signalling 2005;7:761-767 (Pubitemid 40563216)
28. Savaraj N, Wei Y, Unate H, Liu PM, Wu CJ, Wangpaichitr M, et al. Redox regulation of matrix metalloproteinase gene family in small cell lung cancer cells. Free Radical Research 2005;39:373-381
29. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, et al. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 1997;78:285-296
30. SchonwasserDC,MaraisRM,MarshallCJ,ParkerPJ.Activationofthemitogen- activatedproteinkinase/extracellularsignal-regulatedkinasepathwaybyconventional, novel,andatypicalproteinkinaseCisotypes.MolecularandCellularBiology1998;18: 790-798(Pubitemid28063412)
31. Storz G, Polla BS. Transcriptional regulators of oxidative stress-inducible genes in prokaryotes and eukaryotes. EXS 1996;77:239-254
32. StorzP.Reactiveoxygenspeciesintumorprogression.FrontiersinBioscience2005; 10:1881-1896(Pubitemid40529044)
33. Szatrowski TP, Nathan CF. Production of large amount of hydrogen peroxide by humantumor cells. Cancer Res 1991;51:794-798
34. WangX,MartindaleJL,LiuY,HolbrookNJ.TheCellularresponse-oxidativestress: influencesofmitogen-activatedproteinkinasesignallingpathwaysoncellsurvival. BiochemJ1998;333:291-300(Pubitemid28379529)
35. Waskiewicz AJ, Cooper JA. Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol 1995;7:798-805
36. Wu WS, Tsai RK, Chang CH, Wang S, Wu JR, Chang YX. Reactive oxygen species mediated sustained activation of protein kinase C and ERK for migration of human hepatoma cell HepG2. Molecular Cancer Research 2006;4:747-758
37. Yamazaki D, Kurisu S, Takenawa T. Regulation of cancer cell motility through actin reorganization. Cancer Science 2005; 9:379-386 (Pubitemid 41179738)